Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study (Q43522608)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study |
scientific article |
Statements
1 reference
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study (English)
1 reference
Thomas Bachelot
1 reference
Gilles Romieu
1 reference
Mario Campone
1 reference
Véronique Diéras
1 reference
Claire Cropet
1 reference
Florence Dalenc
1 reference
Marta Jimenez
1 reference
Emilie Le Rhun
1 reference
Jean-Yves Pierga
1 reference
Anthony Gonçalves
1 reference
Marianne Leheurteur
1 reference
Julien Domont
1 reference
Maya Gutierrez
1 reference
Hervé Curé
1 reference
Jean-Marc Ferrero
1 reference
Catherine Labbe-Devilliers
1 reference
2 November 2012
1 reference
1 reference
14
1 reference
1
1 reference
64-71
1 reference
Identifiers
1 reference
1 reference